Prevention
RSSArticles
-
Using Cardiac MRI to Detect Suspected Tumors
Among patients with suspected cardiac tumors, cardiac MRI was highly accurate at distinguishing tumor from thrombus and benign from malignant tumors, using subsequent clinical data over five years of follow-up as the diagnostic standard.
-
Vitamin and Mineral Supplements for Cardiovascular Disease
A meta-analysis of systematic reviews and randomized, controlled trials to analyze the role of commonly used dietary supplements for prevention and treatment of cardiovascular disease suggests no significant effect on cardiovascular outcomes or all-cause mortality, although some B vitamins appear to reduce stroke incidence, and B3 appears to increase all-cause mortality.
-
Progression of Coronary Calcium on Statin Treatment
In those treated with statins vs. those who were not, statins decreased plaque volume in plaques with little or no calcium (plaque regression) and increased calcium density without changes in plaque volume in calcified plaques (plaque stabilization).
-
Anticoagulation Plus Antiplatelet Therapy in Chronic Atherosclerosis
An analysis of the COMPASS trial for the secondary endpoint of mortality showed the combination of low-dose rivaroxaban and aspirin significantly lowered the all-cause mortality rate vs. low-dose aspirin alone.
-
Alcohol Consumption and Atrial Fibrillation
An analysis of the UK Biobank database revealed low levels of alcohol consumption, especially with wine and spirits, is associated with the lowest incidence of atrial fibrillation. -
Researchers Observe No Connections Between Statin Therapy, Cognitive Decline
But randomized trials are needed to better detail long-term risk-benefit ratio. -
AAP Recommends Screening All Children for Heart Problems
Around 2,000 Americans younger than age 25 die each year because of sudden cardiac death. -
U.S. Slips in Blood Pressure Management
After years of improvement in this area, investigators recently observed troubling decline in rate control. -
Accounting for Patient Preference, Cardiovascular Disease Risk in Statin Therapy
Researchers weighed patient preferences and risks regarding statin therapy after reviewing 10-year atherosclerotic cardiovascular disease risk scores.
-
Another Agent for Hypercholesterolemia
A pooled analysis of three randomized, controlled trials of inclisiran in patients with atherosclerotic cardiovascular disease or its risk equivalent showed impressive reductions in LDL cholesterol with subcutaneous injections every six months.